Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$27.3K Hold
270
– – ﹤0.01% 528
2026
Q2
$31.9K Hold
270
– – ﹤0.01% 498
2026
Q1
$32.3K Hold
270
– – ﹤0.01% 481
2025
Q4
$36.8K Hold
270
– – ﹤0.01% 458
2025
Q3
$39.8K Hold
270
– – ﹤0.01% 446
2025
Q2
$34.9K Sell
270
-211
-44% -$25.6K ﹤0.01% 459
2025
Q1
$57.5K Buy
481
+229
+91% +$28.4K 0.01% 395
2024
Q4
$29.2K Buy
252
+20
+9% +$2.53K ﹤0.01% 419
2024
Q3
$31.3K Hold
232
– – ﹤0.01% 404
2024
Q2
$31.5K Hold
232
– – 0.01% 390
2024
Q1
$30K Hold
232
– – 0.01% 411
2023
Q4
$26.5K Hold
232
– – ﹤0.01% 407
2023
Q3
$21.1K Sell
232
-10
-4% -$1.03K ﹤0.01% 453
2023
Q2
$27.3K Hold
242
– – 0.01% 426
2023
Q1
$25.3K Hold
242
– – 0.01% 442
2022
Q4
$27K Buy
+242
New +$25.4K 0.01% 434
2018
Q1
– Sell
-265
Closed -$18K – 464
2017
Q4
$18K Hold
265
– – 0.01% 398
2017
Q3
$17K Sell
265
-100
-27% -$5.98K 0.01% 415
2017
Q2
$20K Buy
365
+265
+265% +$13.8K 0.01% 386
2017
Q1
$5K Hold
100
– – ﹤0.01% 436
2016
Q4
$5K Buy
+100
New +$5.07K ﹤0.01% 470

Other funds holding XYL

Grove Bank & Trust's XYL Position: Q3 2026 in Review

Grove Bank & Trust held its Xylem (XYL) position steady in Q3 2026 at 270 shares worth $27.3K. The position accounts for ﹤0.01% of the portfolio, ranked #528.

Grove Bank & Trust first reported a position in XYL in Q4 2016 and has held it in 21 quarters since. The position peaked at $57.5K in Q1 2025. 34 funds tracked by Wall St. Rank hold XYL as of Q3 2026.

  • Grove Bank & Trust held 270 shares of Xylem worth $27.3K as of Q3 2026.
  • Grove Bank & Trust left its Xylem share count unchanged in Q3 2026.
  • Xylem made up ﹤0.01% of Grove Bank & Trust's portfolio in Q3 2026, its #528 holding.
  • Grove Bank & Trust first reported a position in Xylem in Q4 2016 and has held it in 21 quarters since.
  • Grove Bank & Trust's Xylem position peaked at $57.5K in Q1 2025.
  • 34 funds tracked by Wall St. Rank held Xylem as of Q3 2026.

Based on Grove Bank & Trust's 13F filing for Q3 2026, filed 8 Oct 2026.